|
|
||||||||
The Journal of Immunology, Vol 152, Issue 9 4328-4335, Copyright © 1994 by American Association of Immunologists
ARTICLES |
YH Kim, MA Buchholz, FJ Chrest and AA Nordin
Clinical Immunology Section, National Institute on Aging, National Institutes of Health, Baltimore, MD 21224.
The expression and/or up-regulation of several early T cell activation genes is dependent on signals transmitted through the interaction of IL- 2 and IL-2R well before entry of the cells into S phase. In these studies, murine G0 T cells activated by immobilized anti-CD3 and subsequently blocked in late G1 expressed normal surface levels and mRNA for IL-2R alpha, IL-2R beta, and transferrin receptor (TfR). However, there was no expression of p34cdc2, and cyclin-dependent kinase (cdk)-2 was not up-regulated even in the presence of exogenous rIL-2. In addition the accumulation of c-myc-specific mRNA and protein was significantly reduced. Pretreatment of G0 T cells with c-myc antisense oligonucleotide effectively reduced the level of specific c- myc protein induced by activation of the cells by immobilized anti-CD3. The presence of antisense c-myc oligonucleotide inhibited the expression of cdc2 and cdk2 without affecting the expression of IL-2R alpha and blocked the activated T cells in the G1 phase. Together these studies demonstrate that c-myc regulates the expression of these cdk and suggest a role for c-myc in the G1/S transition.
This article has been cited by other articles:
![]() |
Y. Sun and E. A. Clark Expression of the c-myc Proto-oncogene Is Essential for HIV-1 Infection in Activated T Cells J. Exp. Med., May 3, 1999; 189(9): 1391 - 1398. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |